rxstatShortages › Desvenlafaxine

Desvenlafaxine (Pristiq) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 29, 2026

Some Desvenlafaxine products are in shortage in Canada (2 of 17 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 28, 2026.

An SNRI antidepressant used to treat depression.

Products affected
2 / 17
In shortage since
Nov 3, 2025
Est. full return
Aug 28, 2026
Reports on file
45
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TARO-DESVENLAFAXINE
100MG · TABLET (EXTENDED-RELEASE) · TARO PHARMACEUTICALS INC
DIN 02532166 · since Nov 3, 2025, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · TARO PHARMACEUTICALS INC
DIN 02532158 · since May 1, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · TARO PHARMACEUTICALS INC
DIN 02532158 · since May 1, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02458217 · ended May 31, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02538415 · ended Feb 23, 2026 · Demand increase for the drug.
Resolved
APO-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02466988 · ended Jan 2, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02466988 · ended Jan 2, 2026 · Disruption of the manufacture of the drug.
Resolved
DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02535106 · ended Nov 13, 2024 · Disruption of the manufacture of the drug.
Resolved
DESVENLAFAXINE
100MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02535114 · ended Nov 13, 2024 · Disruption of the manufacture of the drug.
Resolved
DESVENLAFAXINE
100MG · TABLET (EXTENDED-RELEASE) · PRO DOC LIMITEE
DIN 02543680 · ended Oct 25, 2024 · Delay in shipping of the drug.
Resolved
APO-DESVENLAFAXINE
100MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02466996 · ended Oct 24, 2024 · Disruption of the manufacture of the drug.
Resolved
JAMP DESVENLAFAXINE
50MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02495139 · ended Jul 16, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 45 reports. All reports are on file with Health Canada.

What's happening

Desvenlafaxine is currently affected by 2 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Desvenlafaxine is classified under “ANTIDEPRESSANTS” (ATC N06AX).

Recent changes

Common questions

What is Desvenlafaxine used for?

An SNRI antidepressant used to treat depression.

When will Desvenlafaxine be back in stock in Canada?

The latest manufacturer estimate is Aug 28, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Desvenlafaxine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antidepressants)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.